223 related articles for article (PubMed ID: 2131715)
1. [IgM monoclonal gammopathy in plasmacytic neoplasms].
Kraj M; Kopeć I; Rostkowska J; Pogłód R; Maj S
Acta Haematol Pol; 1990; 21(2):153-65. PubMed ID: 2131715
[TBL] [Abstract][Full Text] [Related]
2. B-cell malignancy and monoclonal gammopathy, and idiotype of cell surface and serum immunoglobulin.
Sugai S; Takiguchi T; Hirose Y; Konaka Y; Shimizu S; Konda S
Jpn J Clin Oncol; 1983 Sep; 13(3):533-42. PubMed ID: 6417376
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression.
Kyle RA; Rajkumar SV
Br J Haematol; 2007 Dec; 139(5):730-43. PubMed ID: 18021088
[TBL] [Abstract][Full Text] [Related]
4. [Monoclonal gammopathies of undetermined significance called "MGUS"].
Clément F
Schweiz Med Wochenschr; 1989 Jul; 119(27-28):970-8. PubMed ID: 2508215
[TBL] [Abstract][Full Text] [Related]
5. The laboratory diagnosis of plasma cell myeloma and related disorders.
Nawab RA; Azar HA
Orthop Clin North Am; 1979 Apr; 10(2):391-404. PubMed ID: 109804
[TBL] [Abstract][Full Text] [Related]
6. Risk of progression in smouldering myeloma and monoclonal gammopathies of unknown significance: comparative analysis of the evolution of monoclonal component and multiparameter flow cytometry of bone marrow plasma cells.
Pérez-Persona E; Mateo G; García-Sanz R; Mateos MV; de Las Heras N; de Coca AG; Hernández JM; Galende J; Martín-Nuñez G; Bárez A; Alonso JM; Martín A; López-Berges C; Orfao A; San Miguel JF; Vidriales MB
Br J Haematol; 2010 Jan; 148(1):110-4. PubMed ID: 19821821
[TBL] [Abstract][Full Text] [Related]
7. Biclonal gammopathy in multiple myeloma: a case report.
Bakta IM; Sutarka IN
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():544-8. PubMed ID: 10895208
[TBL] [Abstract][Full Text] [Related]
8. 'Mu' heavy chain type 'non-excretory' myeloma.
Guglielmo P; Granata P; Di Raimondo F; Lombardo T; Giustolisi R; Cacciola E
Scand J Haematol; 1982 Jul; 29(1):36-40. PubMed ID: 6812210
[TBL] [Abstract][Full Text] [Related]
9. Regulation of immunoglobulin synthesis by monocytes in multiple myeloma and benign monoclonal gammopathy.
Takeshita A
Clin Exp Immunol; 1986 Dec; 66(3):625-32. PubMed ID: 3568450
[TBL] [Abstract][Full Text] [Related]
10. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
Kelly JJ
Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
[TBL] [Abstract][Full Text] [Related]
11. A GEIL flow cytometry consensus proposal for quantification of plasma cells: application to differential diagnosis between MGUS and myeloma.
Frébet E; Abraham J; Geneviève F; Lepelley P; Daliphard S; Bardet V; Amsellem S; Guy J; Mullier F; Durrieu F; Venon MD; Leleu X; Jaccard A; Faucher JL; Béné MC; Feuillard J;
Cytometry B Clin Cytom; 2011 May; 80(3):176-85. PubMed ID: 21520405
[TBL] [Abstract][Full Text] [Related]
12. Should bone marrow examination be routinely performed for the diagnosis of monoclonal gammopathy of undetermined significance?
Elis A; Radnay J; Shapiro H; Itzhaky D; Manor Y; Lishner M
Isr Med Assoc J; 2006 Dec; 8(12):840-2. PubMed ID: 17214099
[TBL] [Abstract][Full Text] [Related]
13. IgM myeloma: a report of four cases.
Dierlamm T; Laack E; Dierlamm J; Fiedler W; Hossfeld DK
Ann Hematol; 2002 Mar; 81(3):136-9. PubMed ID: 11904738
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of monoclonal gammopathy of undetermined significance and multiple myeloma using flow cytometric characteristics of plasma cells.
Sezer O; Heider U; Zavrski I; Possinger K
Haematologica; 2001 Aug; 86(8):837-43. PubMed ID: 11522540
[TBL] [Abstract][Full Text] [Related]
15. Immunophenotypic aberrations, DNA content, and cell cycle analysis of plasma cells in patients with myeloma and monoclonal gammopathies.
Lima M; Teixeira Mdos A; Fonseca S; Gonçalves C; Guerra M; Queirós ML; Santos AH; Coutinho A; Pinho L; Marques L; Cunha M; Ribeiro P; Xavier L; Vieira H; Pinto P; Justiça B
Blood Cells Mol Dis; 2000 Dec; 26(6):634-45. PubMed ID: 11358356
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal gammopathy in systemic lupus erythematosus.
Ali YM; Urowitz MB; Ibanez D; Gladman DD
Lupus; 2007; 16(6):426-9. PubMed ID: 17664233
[TBL] [Abstract][Full Text] [Related]
17. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
[TBL] [Abstract][Full Text] [Related]
18. Bone-marrow immunophenotypic analysis allows the identification of high risk of progression and immune condition-related monoclonal gammopathy of undetermined significance.
Jerez A; Ortuño FJ; Osma Mdel M; Español I; González AD; Roldán V; de Arriba F; Vicente V
Ann Med; 2009; 41(7):547-58. PubMed ID: 19634064
[TBL] [Abstract][Full Text] [Related]
19. Waldenström macroglobulinaemia and IgM monoclonal gammopathy of undetermined significance: emerging understanding of a potential precursor condition.
McMaster ML; Caporaso N
Br J Haematol; 2007 Dec; 139(5):663-71. PubMed ID: 18021080
[TBL] [Abstract][Full Text] [Related]
20. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.
Verroust P; Mery JP; Morel-Maroger L; Clauvel JP; Richet G; Bouteiller AM; Fumagalli N
Adv Nephrol Necker Hosp; 1971; 1():161-94. PubMed ID: 4377644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
